Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127338771 | 12733877 | 1 | I | 20160906 | 20160912 | 20160912 | EXP | CA-ROCHE-1826490 | ROCHE | 34.00 | YR | M | Y | 0.00000 | 20160912 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127338771 | 12733877 | 1 | PS | Tocilizumab | TOCILIZUMAB | 1 | Unknown | U | 125276 | ||||||||||
| 127338771 | 12733877 | 2 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | U | 0 | TABLET | |||||||||
| 127338771 | 12733877 | 3 | SS | ENBREL | ETANERCEPT | 1 | Unknown | U | 0 | ||||||||||
| 127338771 | 12733877 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
| 127338771 | 12733877 | 5 | SS | IMURAN | AZATHIOPRINE | 1 | Unknown | U | 0 | ||||||||||
| 127338771 | 12733877 | 6 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | THERAPY DURATION: 2 YEARS, THERAPY DURATION: 12 YEARS | U | 0 | |||||||||
| 127338771 | 12733877 | 7 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | U | 0 | 200 | MG | BID | |||||||
| 127338771 | 12733877 | 8 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 6 YEARS, THERAPY DURATION: 5 YEARS | U | 0 | |||||||||
| 127338771 | 12733877 | 9 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | THERAPY DURATION: 7 MONTHS | U | 0 | |||||||||
| 127338771 | 12733877 | 10 | SS | ULTRAVATE | HALOBETASOL PROPIONATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127338771 | 12733877 | 1 | Product used for unknown indication |
| 127338771 | 12733877 | 2 | Product used for unknown indication |
| 127338771 | 12733877 | 3 | Product used for unknown indication |
| 127338771 | 12733877 | 4 | Product used for unknown indication |
| 127338771 | 12733877 | 5 | Product used for unknown indication |
| 127338771 | 12733877 | 6 | Product used for unknown indication |
| 127338771 | 12733877 | 7 | Psoriasis |
| 127338771 | 12733877 | 8 | Product used for unknown indication |
| 127338771 | 12733877 | 9 | Product used for unknown indication |
| 127338771 | 12733877 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127338771 | 12733877 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127338771 | 12733877 | Drug eruption | |
| 127338771 | 12733877 | Drug ineffective | |
| 127338771 | 12733877 | Epistaxis | |
| 127338771 | 12733877 | Hepatic function abnormal | |
| 127338771 | 12733877 | Hypersensitivity | |
| 127338771 | 12733877 | Muscle spasms | |
| 127338771 | 12733877 | Pain in extremity | |
| 127338771 | 12733877 | Pneumonia | |
| 127338771 | 12733877 | Stomatitis | |
| 127338771 | 12733877 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |